Loading Page
Dr. Daniel A. Weiser, MD is a pediatric oncologist in City of New York, NY specializing in pediatric hematology/oncology and general pediatrics. He graduated from Stony Brook University Medical Center, School of Medicine. Dr. Daniel A. Weiser, MD is affiliated with Montefiore Einstein and White Plains Hospital.
Dr. Daniel A. Weiser, MD graduated from Stony Brook University Medical Center, School of Medicine. He completed residency at New York-Presbyterian Hospital. He is certified by the %UNNAVIGATED_TEXT: American Board of Pediatrics and has a state license in New York.
Medical School: Stony Brook University Medical Center, School of Medicine
Residency: New York-Presbyterian Hospital
Board Certification: %UNNAVIGATED_TEXT: American Board of Pediatrics
Licensed In: New York
Dr. Daniel A. Weiser, MD appears to accept the following insurance providers: Aetna, Anthem, Affinity Health Plan, Show more, Amidacare, 1199SEIU Benefit Funds, CDPHP and ArchCare.
According to our sources, Dr. Daniel A. Weiser, MD accepts the following insurance providers:
Dr. Daniel A. Weiser, MD does not have any reviews yet, be the first to leave a review of Dr. Daniel A. Weiser, MD here: Leave a Review
These charts describe general payments received by Dr. Daniel A. Weiser, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$590
$590 |
|
|
$25
IWILFIN $25 |
|
|
$24
$24 |
|
|
$22
OGSIVEO $22 |
| $590 | |
| $70 |
Daniel A Weiser, MD, is a board-certified pediatric hematologist/oncologist with clinical expertise in neuroblastoma and tumors of the adrenal glands, kidneys, liver, and gonads. He serves as Director of the Abdominal Solid Tumor Program and Co-Director of the Childhood Cancer Predisposition (CCP) Clinic at the Children’s Hospital at Montefiore Einstein. Dr Weiser leads a highly specialized, multidisciplinary team dedicated to providing comprehensive and individualized care for children with a broad spectrum of solid tumors. In addition to his clinical leadership, Dr Weiser directs a childhood cancer research laboratory focused on improving outcomes for children with aggressive and treatment-resistant malignancies.
